Prescription drug · ANDA
Levothyroxine Sodium NDC 68071-3887
Levothyroxine sodium 75 ug/1 · Tablet · Oral · NuCare Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-3887-3 | 68071388703 | 30 TABLET in 1 BOTTLE (68071-3887-3)Marketed from Jan 7, 2026 | |
| 68071-3887-9 | 68071388709 | 90 TABLET in 1 BOTTLE (68071-3887-9)Marketed from Aug 28, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Levothyroxine Sodium
- Generic name (nonproprietary)
- levothyroxine sodium
- Active ingredients
- Levothyroxine sodium — 75 ug/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals, Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211417
- Marketing start
- Listing expires
- Other FDA classes
- Thyroxine (Chemical structure)
- Identifiers
- Product ID 68071-3887_47cfe577-b4ca-d35e-e063-6394a90ad8c4SPL ID 47cfe577-b4ca-d35e-e063-6394a90ad8c4SPL set ID 3d737f79-7fc9-4221-e063-6394a90ac9aaRxCUI 966222UNII 9J765S329GUPC 0368071388794
- Pharmacologic class
- l-Thyroxine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071388703followed by a unit qualifier and the quantityPackage 68071-3887-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 211417
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine sodium 175 ug/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8811 |
| Levothyroxine Sodium | Levothyroxine sodium 200 ug/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-403 |
| Levothyroxine Sodium | Levothyroxine sodium 150 ug/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-401 |
| Levothyroxine Sodium | Levothyroxine sodium 125 ug/1 | TabletOral | A-S Medication Solutions | 50090-7885 |
| Levothyroxine Sodium | Levothyroxine sodium 175 ug/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-402 |
| Levothyroxine Sodium | Levothyroxine sodium 125 ug/1 | TabletOral | A-S Medication Solutions | 50090-7886 |
| Levothyroxine Sodium | Levothyroxine sodium 300 ug/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-404 |
| Levothyroxine Sodium | Levothyroxine sodium 88 ug/1 | TabletOral | A-S Medication Solutions | 50090-7901 |
| Levothyroxine Sodium | Levothyroxine sodium 25 ug/1 | TabletOral | A-S Medication Solutions | 50090-7909 |
| Levothyroxine Sodium | Levothyroxine sodium 150 ug/1 | TabletOral | A-S Medication Solutions | 50090-7636 |
| Levothyroxine Sodium | Levothyroxine sodium 88 ug/1 | TabletOral | A-S Medication Solutions | 50090-7902 |
| Levothyroxine Sodium | Levothyroxine sodium 150 ug/1 | TabletOral | A-S Medication Solutions | 50090-7637 |
| Levothyroxine Sodium | Levothyroxine sodium 25 ug/1 | TabletOral | A-S Medication Solutions | 50090-7910 |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/1 | TabletOral | A-S Medication Solutions | 50090-7648 |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/1 | TabletOral | A-S Medication Solutions | 50090-7649 |
| Levothyroxine Sodium | Levothyroxine sodium 75 ug/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8806 |
| Levothyroxine Sodium | Levothyroxine sodium 100 ug/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8807 |
| Levothyroxine Sodium | Levothyroxine sodium 50 ug/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4005 |
| Levothyroxine Sodium | Levothyroxine sodium 200 ug/1 | TabletOral | A-S Medication Solutions | 50090-8059 |
| Levothyroxine Sodium | Levothyroxine sodium 125 ug/1 | TabletOral | A-S Medication Solutions | 50090-8056 |
Showing 20 of 39.